Novosibirsk State Medical University is a medical university in Novosibirsk, Russia for training qualified doctors. It was organized in 1935 when the medical faculty was opened. Until 1999 it was known as the Novosibirsk medical institute. From 1999 to 2005 it is the Novosibirsk state medical academy.

During the past decade, Novosibirsk Reg. Clinical Cardiology Dispensary conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Novosibirsk Reg. Clinical Cardiology Dispensary" are "Dyslipidemia" (3 trials), "Hypercholesterolemia" (2 trials) and "Primary Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Novosibirsk Reg. Clinical Cardiology Dispensary" in a lesser frequency.

Most popular intervention types in "Novosibirsk Reg. Clinical Cardiology Dispensary" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (3 trials), "Atorvastatin" (1 trials) and "Simvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novosibirsk Reg. Clinical Cardiology Dispensary" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Novosibirsk Reg. Clinical Cardiology Dispensary". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Novosibirsk Reg. Clinical Cardiology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novosibirsk Reg. Clinical Cardiology Dispensary, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".